ArticleFrontiers in robotics and AI2026
Human-AI co-research on design and evaluation of Embodied Conversational Agent in rehabilitation contexts.
Article in Frontiers in robotics and AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite strong evidence that repetitive home-based rehabilitation improves functional recovery after stroke, current delivery models still show gaps in continuity of care and patient engagement. AI-driven Embodied Conversational Agents (ECAs) could provide personalized home support through natural-language guidance on prescribed exercises, reinforcement of neuroplasticity, clarification of therapeutic principles, and motivational support. However, clinical deployment remains challenging. Many robotic platforms lack real-time interaction capabilities such as speech processing, gesture execution, and attention tracking, while Large Language Models (LLMs) may produce factual errors or inconsistent responses. Early development is also constrained by limited access to real users due to practical and ethical considerations. Methods: To address these challenges, we propose a Design-Based Research methodology for human-AI co-design and evaluation of ECAs (co-AI DBR), where generative AI facilitates iterative cycles of design, testing, and refinement. Co-AI DBR combines synthetic patient generation with real-code execution to simulate, emulate, and evaluate the ECA platform and its LLM-based conversational pipeline. To validate the method in a post-stroke rehabilitation context, a virtual ECA was first tested with synthetic patients to assess technical implementation and accuracy of LLM responses. A pilot deployment using the Furhat robot as an ECA was then conducted with patient relatives and rehabilitation professionals to evaluate the voice interface and augmented communication. Results: LLM responses to questions from real participants showed higher lexical diversity (MTLD ≈ 134 vs. 93.9) and lower repetition (Yule's K ≈ 66.8 vs. 115.4) than responses to synthetically generated questions. Responses remained factually consistent, with no contradictions and complete gender invariance, although slightly lower hapax rates were observed (88.8% vs. 99.4%). Usability scores were higher among relatives (M = 86.67) than professionals (M = 72.50), while Intrinsic Motivation Inventory scores indicated similarly high motivation in both groups (M = 6.32 vs. 6.12). Discussion: The results suggest that co-AI DBR can support early design and evaluation of ECAs when direct patient testing is limited. By combining synthetic patient generation with real-code execution, generative AI supports iterative knowledge building during the prototyping and refinement of LLM-based ECAs. This methodology enables the practical development of ECA to support home-based post-stroke rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.